Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

48 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Soluble receptor of advanced glycation end products levels are related to ischaemic aetiology and extent of coronary disease in chronic heart failure patients, independent of advanced glycation end products levels: New Roles for Soluble RAGE.
Raposeiras-Roubín S, Rodiño-Janeiro BK, Grigorian-Shamagian L, Moure-González M, Seoane-Blanco A, Varela-Román A, Alvarez E, González-Juanatey JR. Raposeiras-Roubín S, et al. Eur J Heart Fail. 2010 Oct;12(10):1092-100. doi: 10.1093/eurjhf/hfq117. Epub 2010 Aug 3. Eur J Heart Fail. 2010. PMID: 20685687 Free article.
Relation of soluble receptor for advanced glycation end products to predict mortality in patients with chronic heart failure independently of Seattle Heart Failure Score.
Raposeiras-Roubín S, Rodiño-Janeiro BK, Grigorian-Shamagian L, Moure-González M, Seoane-Blanco A, Varela-Román A, Almenar-Bonet L, Alvarez E, González-Juanatey JR. Raposeiras-Roubín S, et al. Am J Cardiol. 2011 Mar 15;107(6):938-44. doi: 10.1016/j.amjcard.2010.11.011. Epub 2011 Jan 19. Am J Cardiol. 2011. PMID: 21247530
Evidence for a role of advanced glycation end products in atrial fibrillation.
Raposeiras-Roubín S, Rodiño-Janeiro BK, Grigorian-Shamagian L, Seoane-Blanco A, Moure-González M, Varela-Román A, Álvarez E, González-Juanatey JR. Raposeiras-Roubín S, et al. Int J Cardiol. 2012 Jun 14;157(3):397-402. doi: 10.1016/j.ijcard.2011.05.072. Epub 2011 Jun 8. Int J Cardiol. 2012. PMID: 21652096
Predictive value of advanced glycation end products for the development of post-infarction heart failure: a preliminary report.
Raposeiras-Roubín S, Rodiño-Janeiro BK, Paradela-Dobarro B, Grigorian-Shamagian L, García-Acuña JM, Aguiar-Souto P, Jacquet-Hervet M, Reino-Maceiras MV, Alvarez E, González-Juanatey JR. Raposeiras-Roubín S, et al. Cardiovasc Diabetol. 2012 Aug 21;11:102. doi: 10.1186/1475-2840-11-102. Cardiovasc Diabetol. 2012. PMID: 22909322 Free PMC article.
Statins modulate feedback regulation mechanisms between advanced glycation end-products and C-reactive protein: evidence in patients with acute myocardial infarction.
Paradela-Dobarro B, Raposeiras-Roubín S, Rodiño-Janeiro BK, Grigorian-Shamagian L, García-Acuña JM, Aguiar-Souto P, Jacquet-Hervet M, Reino-Maceiras MV, González-Juanatey JR, Alvarez E. Paradela-Dobarro B, et al. Eur J Pharm Sci. 2013 Jul 16;49(4):512-8. doi: 10.1016/j.ejps.2013.05.001. Epub 2013 May 9. Eur J Pharm Sci. 2013. PMID: 23665412
Fluorescent advanced glycation end products and their soluble receptor: the birth of new plasmatic biomarkers for risk stratification of acute coronary syndrome.
Raposeiras-Roubín S, Rodiño-Janeiro BK, Paradela-Dobarro B, Grigorian-Shamagian L, García-Acuña JM, Aguiar-Souto P, Jacquet-Hervet M, Reino-Maceiras MV, González-Juanatey JR, Álvarez E. Raposeiras-Roubín S, et al. PLoS One. 2013 Sep 13;8(9):e74302. doi: 10.1371/journal.pone.0074302. eCollection 2013. PLoS One. 2013. PMID: 24058542 Free PMC article.
48 results